These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33786859)

  • 1. Prospects for personalization of depression treatment with genome sequencing.
    Borczyk M; Piechota M; Rodriguez Parkitna J; Korostynski M
    Br J Pharmacol; 2022 Sep; 179(17):4220-4232. PubMed ID: 33786859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives for therapy of treatment-resistant depression.
    Papp M; Cubala WJ; Swiecicki L; Newman-Tancredi A; Willner P
    Br J Pharmacol; 2022 Sep; 179(17):4181-4200. PubMed ID: 34128229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and prospects in pharmacogenetics of antidepressant drugs.
    Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models.
    Noordam R; Avery CL; Visser LE; Stricker BH
    Pharmacogenomics; 2016 Jun; 17(9):1029-40. PubMed ID: 27248517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics with antidepressants in the STAR*D study.
    Lin E; Chen PS
    Pharmacogenomics; 2008 Jul; 9(7):935-46. PubMed ID: 18597655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association studies in pharmacogenomics of antidepressants.
    Lin E; Lane HY
    Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of antidepressant treatment effects.
    Licinio J; Wong ML
    Dialogues Clin Neurosci; 2011; 13(1):63-71. PubMed ID: 21485747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine pharmacogenetics: a comprehensive review.
    Suwała J; Machowska M; Wiela-Hojeńska A
    Pharmacogenomics; 2019 Jul; 20(11):829-845. PubMed ID: 31368838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of antidepressant response: A polygenic approach.
    García-González J; Tansey KE; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Žagar T; Czerski PM; Jerman B; Buttenschøn HN; Schulze TG; Zobel A; Farmer A; Aitchison KJ; Craig I; McGuffin P; Giupponi M; Perroud N; Bondolfi G; Evans D; O'Donovan M; Peters TJ; Wendland JR; Lewis G; Kapur S; Perlis R; Arolt V; Domschke K; ; Breen G; Curtis C; Sang-Hyuk L; Kan C; Newhouse S; Patel H; Baune BT; Uher R; Lewis CM; Fabbri C
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():128-134. PubMed ID: 28159590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic studies: a tool to improve antidepressant therapy.
    Ramos M; Berrogain C; Concha J; Lomba L; García CB; Ribate MP
    Drug Metab Pers Ther; 2016 Dec; 31(4):197-204. PubMed ID: 27889704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression.
    Islam F; Gorbovskaya I; Müller DJ
    Adv Exp Med Biol; 2021; 1305():231-255. PubMed ID: 33834403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Utility of CYP2D6 and CYP2C19 Variants to Guide Pharmacological Treatment in Complex Unipolar Major Depression: A Pilot Longitudinal Study.
    Ramaraj R; Al-Mahayri ZN; Saleous R; Abdel Aziz K; Al-Mugaddam F; Al-Sabousi M; Alhassani A; Ahbabi NAA; Stip E; Patrinos GP; Ali BR; Arnone D
    Psychiatr Q; 2023 Sep; 94(3):435-447. PubMed ID: 37490261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of and Barriers to Pharmacogenomics-Guided Treatment for Major Depressive Disorder.
    Ahmed AT; Weinshilboum R; Frye MA
    Clin Pharmacol Ther; 2018 May; 103(5):767-769. PubMed ID: 29388201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.
    Fabbri C; Di Girolamo G; Serretti A
    Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):487-520. PubMed ID: 23852853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder.
    Peterson K; Dieperink E; Anderson J; Boundy E; Ferguson L; Helfand M
    Psychopharmacology (Berl); 2017 Jun; 234(11):1649-1661. PubMed ID: 28456840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors.
    Gressier F; Verstuyft C; Hardy P; Becquemont L; Corruble E
    J Neural Transm (Vienna); 2015 Jan; 122(1):35-42. PubMed ID: 25047911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants in major depressive disorder: From pathophysiology to therapy.
    Gonda X; Petschner P; Eszlari N; Baksa D; Edes A; Antal P; Juhasz G; Bagdy G
    Pharmacol Ther; 2019 Feb; 194():22-43. PubMed ID: 30189291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials.
    Arnone D; Omar O; Arora T; Östlundh L; Ramaraj R; Javaid S; Govender RD; Ali BR; Patrinos GP; Young AH; Stip E
    Neurosci Biobehav Rev; 2023 Jan; 144():104965. PubMed ID: 36463971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of common genetic variants to antidepressant response.
    Tansey KE; Guipponi M; Hu X; Domenici E; Lewis G; Malafosse A; Wendland JR; Lewis CM; McGuffin P; Uher R
    Biol Psychiatry; 2013 Apr; 73(7):679-82. PubMed ID: 23237317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning, pharmacogenomics, and clinical psychiatry: predicting antidepressant response in patients with major depressive disorder.
    Bobo WV; Van Ommeren B; Athreya AP
    Expert Rev Clin Pharmacol; 2022 Aug; 15(8):927-944. PubMed ID: 35968639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.